News
Sarepta Therapeutics lays off 493 workers amid FDA probe, stock drop, and concerns over its gene therapy treatment, Elevidys.
Seven Ohio companies reported 591 layoffs in June, per WARN Act notices filed with the state. Largest cuts came from Ohio ...
14d
WCMH Columbus on MSNSarepta Therapeutics lays off 500 employees amid FDA investigation, including 80 in ColumbusSarepta Therapeutics announced it is laying off nearly 500 employees this week, including 80 at its Easton location. According to a mass layoff notice filed with the state, biotech company Sarepta ...
Hosted on MSN11d
Sarepta Therapeutics laying off dozens in Ohio, won't comply with FDA request to halt therapyThe ask comes days after Sarepta, which has a major presence in Columbus, announced it would lay off 500 workers, including 80 in central Ohio. The Food and Drug Administration ... when it announced ...
Hosted on MSN15d
Sarepta Therapeutics laying off 80 employees in Ohio - MSNSarepta Therapeutics to lay off 493 workers, including 80 in Ohio, amid FDA probe, stock plunge, and concerns over Duchenne gene therapy Elevidys.
Sarepta Therapeutics announced it has laid off more than one-third of its workforce, a drastic cost-cutting move following ...
Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning By Gabrielle Masson Jul 16, 2025 4:59pm Sarepta Sarepta Therapeutics biotech layoffs Duchenne muscular dystrophy (DMD) ...
A filing with the state details the Columbus job cuts for a biotech cutting more than one-third of its workforce.
This week on "The Readout LOUD": Just how many employees is Sarepta Therapeutics laying off? And why did the FDA reject Ultragenyx's rare disease drug over manufacturing qualms?
Some results have been hidden because they may be inaccessible to you
Show inaccessible results